Coagil-VII®
(INN: eptacog alfa (activated))
Recombinant activated coagulation factor VII, which is required for the treatment of inhibitor form of haemophilia. It is also used during surgical interventions in patients with inhibitor form of haemophilia or Glanzmann thrombasthenia.
GENERIUM is the only company in the world, which manufactures three recombinant coagulation factors (FVII, FVII and FIX) for the treatment of hemophilia A and B, including its inhibitor form.